HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Psoralen plus ultraviolet A light may be associated with clearing of peripheral blood disease in advanced cutaneous T-cell lymphoma.

AuthorsBrian A Raphael, Kelly A Morrissey, Ellen J Kim, Carmela C Vittorio, Alain H Rook
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 65 Issue 1 Pg. 212-4 (Jul 2011) ISSN: 1097-6787 [Electronic] United States
PMID21679821 (Publication Type: Letter)
Chemical References
  • Anticarcinogenic Agents
  • Immunosuppressive Agents
Topics
  • Anticarcinogenic Agents (therapeutic use)
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Lymphoma, T-Cell, Cutaneous (drug therapy, pathology)
  • Male
  • Neoplasm Invasiveness (pathology)
  • Neoplasm Staging
  • PUVA Therapy (methods)
  • Risk Assessment
  • Sampling Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: